Neurogene Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Neurogene Inc.
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.
/ 
Frequently asked questions
To buy Neurogene Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Neurogene Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Neurogene Inc. is NLTX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Neurogene Inc. has its primary listing on NASDAQ. You can trade Neurogene Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Neurogene Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Neurogene Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Neurogene Inc..